
In this episode of the Vitality Vision podcast, Greg Bennett, along with Voloridge Health's President Barry Miller, and CEO and CSO David Vogel, discuss their experiences and key takeaways from the Eudemonia Summit, highlighting Voloridge Health's presence and the positive reception of their health assessment booth. They delve into the significance of specific blood biomarkers—Cystatin C, Hemoglobin A1c, CRP, GGT, and APOB—for proactive health monitoring, sharing personal anecdotes and data-driven insights. The conversation also explores the limitations of standard reference ranges in blood tests, the importance of personalized health metrics, and future plans for Voloridge Health, including the launch of a consumer app in 2026 with features for tracking health scores, interventions, and integrating genetics and proteomics for more advanced disease prediction.
Sign in to continue reading, translating and more.
Continue